TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+4.56%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.67B
AUM Growth
+$41.2M
(+1.6%)
Cap. Flow
-$9.43M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
35.39%
Holding
233
New
11
Increased
50
Reduced
32
Closed
29
Top Buys
| 1 |
AbbVie
ABBV
|
$29.9M |
| 2 |
Illumina
ILMN
|
$20.5M |
| 3 |
Steris
STE
|
$20.4M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$18.9M |
| 5 |
Humana
HUM
|
$15.5M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$42.2M |
| 2 |
Thermo Fisher Scientific
TMO
|
$33.8M |
| 3 |
UnitedHealth
UNH
|
$29.4M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$23.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$20.7M |
Sector Composition
| 1 | Healthcare | 95.21% |
| 2 | Real Estate | 2.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
226
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| – | – |
-25,051
| Closed | -$3.07M |
|
|
MNTA
227
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| – | – |
-111,768
| Closed | -$3.72M |
|
|
PRNB
228
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| – | – |
-60,390
| Closed | -$3.61M |
|
|
TTPH
229
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| – | – |
-42,965
| Closed | -$108K |
|
|
PTLA
230
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| – | – |
-109,246
| Closed | -$1.97M |
|
231
Allogene Therapeutics
ALLO
$255M
| – | – |
-216,069
| Closed | -$9.25M |
|